Literature DB >> 32420701

Clinical characteristics and outcomes of 566 Thais with systemic sclerosis: A cohort study.

Chingching Foocharoen1, Udomlack Peansukwech2, Ajanee Mahakkanukrauh1, Siraphop Suwannaroj1, Patnarin Pongkulkiat1, Penpiriya Khamphiw1, Ratanavadee Nanagara1.   

Abstract

BACKGROUND: Most Thai patients with systemic sclerosis (SSc) have diffuse cutaneous SSc (dcSSc) unlike most Caucasians and some Asians. A longitudinal cohort study among Thai dcSSc is needed.
OBJECTIVES: We aimed to determine the overall clinical characteristics, define the clinical difference between limited cutaneous SSc (lcSSc) and dcSSc, and ascertain the mortality rate and the factors associated with mortality.
METHOD: We conducted a cohort study including 566 Thai adult SSc patients between January 2013 and June 2019. Clinical difference between lcSSc and dcSSc was investigated using generalized estimating equations (GEE).
RESULTS: Females presented more than males (356 vs 210 cases). The majority of cases were dcSSc (411; 72.6%). The median duration of disease at the time of pulmonary fibrosis (PF) detection was 2.5 years, pulmonary arterial hypertension 8.1 years, and renal crisis 4.1 years. By GEE analysis, dcSSc was significantly associated with salt-and-pepper skin, hand deformity, and every 1-point increase in modified Rodnan skin score (mRSS). A greater mortality risk was associated with age at onset >60 years (hazards ratio [HR] 5.5), a World Health Organization functional class (FC) III (HR 5.1), FC IV (HR 34.8), edematous skin (HR 11.4), early onset of PF (HR 1.7), each 5-point increase in the mRSS (HR 4.5), and ≥2 internal organ involvements (HR 10.1).
CONCLUSION: dcSSc is a common SSc subset among Thais. PF was an early complication in SSc and earlier PF detection was associated with a poorer prognosis. Elderly onset, high FC, severe skin tightness, and multiple organ involvements were associated with a greater mortality risk.
© 2020 Asia Pacific League of Associations for Rheumatology and John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  clinical trial; cohort study; mortality; scleroderma; systemic sclerosis

Mesh:

Year:  2020        PMID: 32420701     DOI: 10.1111/1756-185X.13859

Source DB:  PubMed          Journal:  Int J Rheum Dis        ISSN: 1756-1841            Impact factor:   2.454


  6 in total

1.  Elevated baseline serum creatine kinase in Thai early systemic sclerosis patients is associated with high incidence of cardiopulmonary complications and poor survival: an inception cohort study.

Authors:  Suparaporn Wangkaew; Jirapath Intum; Narawudt Prasertwittayakij; Juntima Euathrongchit
Journal:  Clin Rheumatol       Date:  2022-07-07       Impact factor: 3.650

2.  Prevalence and clinical associations with primary hypogonadism in male systemic sclerosis.

Authors:  Sapol Thepwiwatjit; Suranut Charoensri; Wichien Sirithanaphol; Ajanee Mahakkanukrauh; Siraphop Suwannaroj; Chingching Foocharoen
Journal:  J Scleroderma Relat Disord       Date:  2022-07-24

3.  Musculoskeletal ultrasound of the shoulder in systemic sclerosis.

Authors:  Vatakan Surat; Patpiya Sirasaporn; Chingching Foocharoen
Journal:  J Scleroderma Relat Disord       Date:  2022-04-10

Review 4.  Systemic sclerosis in Asians: Are there racial differences?

Authors:  Sue-Ann Ng; Andrea Hsiu Ling Low
Journal:  J Scleroderma Relat Disord       Date:  2022-02-03

5.  Nailfold capillaroscopy for the early diagnosis of the scleroderma spectrum of diseases in patients without Raynaud's phenomenon.

Authors:  Cassandra Hong; Ling Xiang; Seyed Ehsan Saffari; Andrea Hl Low
Journal:  J Scleroderma Relat Disord       Date:  2022-04-21

6.  Development and validation of machine learning for early mortality in systemic sclerosis.

Authors:  Chingching Foocharoen; Wilaiphorn Thinkhamrop; Nathaphop Chaichaya; Ajanee Mahakkanukrauh; Siraphop Suwannaroj; Bandit Thinkhamrop
Journal:  Sci Rep       Date:  2022-10-13       Impact factor: 4.996

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.